Loading...
Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration
PURPOSE: To review published evidence for a treatment interval extension to ≥12-weeks in neovascular macular degeneration treated with intravitreal Aflibercept. METHODS: A systematic search was performed in the NCBI/PubMed database to identify pro- and retrospective studies retrieved by the key term...
Na minha lista:
| Udgivet i: | Clin Ophthalmol |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6650619/ https://ncbi.nlm.nih.gov/pubmed/31409968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S185756 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|